You cannot buy generic Zetonna (ciclesonide) at this time. The next patent for Zetonna is set to expire in February 2014, and it's possible that a generic version could be introduced after this date. Although ciclesonide is considered the "generic name" for Zetonna, it is not actually a generic version of the drug.
Can I Buy Generic Zetonna?
Zetonna™ (ciclesonide) is a prescription steroid nasal spray approved to treat nasal allergies (known medically as allergic rhinitis). It can be used to treat seasonal allergies or year-round allergies (perennial allergies) in adults and children as young as 12 years old. Zetonna belongs to a group of medications known as corticosteroids, or just "steroids" for short.
Zetonna is manufactured by Sunovion Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Zetonna from being manufactured in the United States.
When Will a Generic Version Be Available?
The first patent for Zetonna expired in April 2013. Yet, no generic versions are available. This suggests that another, later-expiring patent may still be providing protection for the drug. The next patent is set to expire in February 2014. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Zetonna uses. Once the patent expires, there may be several companies that manufacture a generic Zetonna drug.
Because Zetonna is not yet available as a generic, your insurance company may require you to try a different generic steroid nasal spray before it will cover Zetonna. These situations are becoming more common as insurance companies try to limit rising healthcare costs. In this situation, your pharmacist and healthcare provider can help you choose a nasal spray that will be covered by your insurance plan.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 13, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click